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After demonstrating theoretical and practical competences, parents com-
menced home monitoring. We analysed the proportion of INR within the
target range, the incidence of anticoagulant related adverse events and the
quality of life of children and parents.
Results: We included 48 children (between 2 months and 17 years old).
Eighteen patients had a mitral valve replacement and 6 an aortic valve replace-
ment. Fifteen patients had a total cavopulmonary derivation, 7 a dilated cardi-
omyopathy, 1 coronary aneurysms after Kawasaki disease and 1 an
antiphospholipid syndrome. Twenty-eight patients received anticoagulation
therapy for the first time and 20 had been treated for a long time and switched
from venipuncture to point-of-care monitor. The results of the theoretical test
of parents were excellent (average 17.3/20). Only 3 families had practical dif-
ficulties at home. 65% of INRs were within the target range. There were no
haemorrhagic and thrombosis complications. The quality of life was improved.
Conclusion: This education and training program was perfectly safe and
improved the quality of life of patients and parents. The use of similar educa-
tion program may serve to improve the outcomes of home monitoring for anti-
coagulation therapy in children.
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The aim of this retrospective study was to describe features ofinfective
endocarditis (IE) in adults with congenital heart disease (CHD).
Methods: The records of all episodes of IE diagnosed from 1974, in
patients with CHD and more than 18 years of age at diagnosis, were retrospec-
tively reviewed.
Results: Fourty-four episodes of IE occurred, 36 after 1990 (81.8%), 28 males
(63.6%). Age at diagnosis was 30.3±9years (median 28years). Ten were recurrent
episodes (22.7%). CHD was previously repared in 15 cases (34%), palliated in 7
(16%) and non-operated in 22 (50%). Dental causes were predominant (34%),
followed by cutaneous causes (25%) ; others were postoperative (4.5%), miscel-
laneous (7%) or unknown causes (29.5%). A microbial agent as identified in
95.4% of the cases : oral streptococcus and staphylococcus aureus were the
leading causative agents (respectively 41% and 36%). Left heart locations were
predominant (75%). Severe clinical cardiac complication occurred in 10 cases
(23%), an echocardiographic complication in 18 (40%). Twenty-four patients
experienced embolic events (54.5%) ; early surgical treatment was required in
25% of the cases. Three patients died due to IE (6.8%). Antibiotic prophylaxis
had been neglicted despite known risk in 41% of the cases.
Conclusion: IE is an ongoing life-threatening complication in adults with
CHD, with a significant morbidity, a high rate of prophylaxis negligence and
of recurrence.
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Introduction: Pulmonary arterial hypertension (PAH) is a devastating dis-
ease with poor survival but there are limited data describing its impact in the
paediatric population.
Objective: The objectives of this national prospective registry were to col-
lect clinical and epidemiological data and to investigate the outcome of chil-
dren with PAH.
Methods: All consecutive patients <18 years with PAH seen in 16 referral
PAH centres in France were included and evaluated after 1 and 2 years of follow-
up for WHO functional class (FC), 6-minute walk distance (6MWD) and quality
of life (QoL; CHQ-PF50 questionnaire). Persistent pulmonary hypertension of the
newborn and PAH due to congenital heart disease (CHD) were excluded.
Results: Fifty patients were included between May 2005 and June 2006. Mean
age at diagnosis was 8.7 ± 5.4 years and male/female ratio was 1/1. The preva-
lence of pediatric PAH was 4.2 cases/million. A history of prematurity, cancer and
major surgery was noticed in respectively 19%, 6% and 4% of patients. At inclu-
sion, 28% of patients were in WHO FC III or IV. Aetiology of PAH was idio-
pathic in 60%; familial in 10%, associated with but not due to CHD in 24%,
related to connective tissue disease in 4% and to portal hypertension in 2%.
Nine patients (018%) died during the 2-year follow up. Survival estimates
at 1 and 2 years were 86% and 82%. Seventy three percents of patients
improved or did not change WHO FC (n = 44). Patients remained stable
regarding 6MWD (n = 25), hemodynamics (n = 11), and QoL (n = 19). During
the 2-year follow-up, combination of PAH-specific therapies was increasingly
prescribed (44% patients vs. 22% at inclusion).
Conclusions: This first national paediatric registry showed (1) the presence
of multiple PAH aetiologies in children, that could be different from those
seen in adults, (2) the association with other co-morbidities, and (3) the stabi-
lization or even improvement in patient’s condition with the therapeutic man-
agement recommended in the current era.
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Background: TGFBR2 mutations were recently recognized among
patients with a Marfan-like phenotype and have been associated with poor car-
diovascular prognosis (early deaths, aortic dissections or early surgery for tho-
racic ascending aorta aneurysm).
Methods: Clinical features and outcomes were analysed in a group of 71
patients (including 22 children) with a TGFBR2 mutation. Patients were com-
pared with age- and gender-matched patients harbouring the FBN1 mutation
(FBN1 group n=243).
Results: The proportion of patients with aortic dilatation was similar in the
TGFBR2 group and in the FBN1 group in both adults [74 % vs. 76 %] and
children [86 %vs. 86 %] and aortic dilatation was very variable in both
TGFBR2 and FBN1 groups.
The incidence and average age of thoracic aortic surgery for aortic dissec-
tion or aortic dilatation were similar in the 2 groups (31% vs. 27% and 35±16
vs. 39±13 years, NS).
Both the frequency and the age of occurrence of aortic dissection were sim-
ilar in the TGFBR2 and the FBN1 groups for the ascending aorta [14 % vs. 10
%, p=0.26; 38±12 vs. 39±9 years, p=0.82] and for the descending aorta (3/71
vs. 8/243, p=0.72; 34±6 vs. 44±10 years, p=0.16).
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In contrast, aortic dilatation, dissection or sudden death was the index event
leading to genetic diagnosis within the family in 65% of families with TGFBR2
mutations and only 32% in families with FBN1 mutations (p = 0.002).
When these family members were included in the survival analysis, mor-
tality was worse in TGFBR2 families than in FBN1 families (p= 0.017)
whereas it was similar if only patients benefiting for preventive care (i.e. in
whom the mutation had been identified) were included (p = 0.39).
Conclusions: The wide clinical spectrum of patients with TGFBR2 gene
mutations underscores the importance of molecular biology for early diag-
nosis. The prognosis of a patient depends on the clinical expression of the dis-
ease and not solely on the presence of a mutation in the TGFBR2 gene.
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Radiofrequency (RF) ablation of accessory pathway (AP) is widely used in
Wolff-Parkinson-White syndrome (WPW), but the indications remain contro-
versial in children and teenagers. The purpose of the study was to evaluate the
clinical and electrophysiological factors associated with the indications of AP
ablation in the youth.
Methods: 133 children and teenagers aged from 5 to 18 years (13.5±3)
were admitted for a WPW and electrophysiological study (EPS) either for
tachycardia, syncope or they were asymptomatic. EPS was performed in con-
trol state and after isoproterenol. Then RF ablation was proposed in case of
recurrent tachycardias or induction of rapid atrial fibrillation (AF).
Results: AP ablation was indicated in 51 children (38 %), several years after
initial evaluation in 5 of them (group I), and was not performed in 82 children
(group II). The indications did not differ significantly from the adult population
(232/504, 46 %). Clinical and electrophysiological data of groups I and II were
compared. Group I was older than group II (15±2 vs 13±4) (p<0.001); male sex
was more frequent in group I (72.5 %) than in group II (56 %) (p<0.05); group
I was less frequently asymptomatic (27 %) than group II (55 %) (p< 0.01) and
had more frequently spontaneous reentrant tachycardias than group II (49 % vs
28 %) (p< 0.05). Syncope was as frequent in group I (21.5 %) as II (18%). At
EPS, group I had a more rapid conduction through AP than group II, in control
state (208±68 b/min vs 176±53, p< 0.001), but not after isoproterenol (245±74
vs 230±63, NS). Reentrant tachycardia was induced more frequently in group I
(70.5 %) than II (37.5 %) (p< 0.001). AF was induced more frequently in group
I 35 %) than in group II (11 %). Malignant forms (rapid AF) were more frequent
in group I (31 %) than in group II (5 %) (p< 0.001). Failures of ablation were
as frequent in children (8 %) as in adults (2.5 %) (NS).
Conclusions: The indications of AP ablation in the young population are
based on recommended data and are similar to those of adults, with a similar
risk of failure; they concern symptomatic or high risk children. The boys are
referred more frequently than girls for the ablation.
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This study is to report the first largest French experience with ventricular
assist device (VAD) in children.
Material and methods: From 2005 to 2009, 13 patients less than 18 years
of age, needed pulsatile ventricular mechanical support at Lyon University
Medical Center. Their clinical data, echocardiographic records and outcomes
were reviewed.
Results: Four females and 9 males, aged 0.1 to 16 years (med 1.4) were
implanted with pulsatile VAD, Berlin Heart Excort* (12 cases) or Thoratec* (1
case). Four had left ventricular support and 9 biventricular, for either cardiogenic
shock with cardiac arrest in 4, or uncontrolled low cardiac output in 9. Under-
lying cardiac diseases included: 12 dilated cardiomyopathies (due to : chemo-
therapy in 1, ischemic in 1, myocardial non-compaction in 2, idiopathic in 8),
and myocarditis in 1. Duration of support varied from 4 to 125 days (med 37).
Nine patients were extubated while on support (69%). Three infants, all less than
18 months of age, experienced stroke due to cerebral embolia (23%) and 3 had
an hemorragic complication. Three patients died on support (23%), at 8th, 23rd,
60th day, from sepsis, multivisceral embolia and hemorrhage respectively. Two
patients were successfully weaned off support at 19th and 37th day (15.4%), 7
underwent heart transplantation (53.8%) and 1 is still on support.
Conclusion: Despite a higher thrombo-embolic risk in infants, our experi-
ence of pulsatile VAD in children is encouraging and shows a good survival
rate of 77%.
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Little is known about Kawasaki Disease (KD) features in France. The aims of
this retrospective single-center study were to assess the characteristics of a French
KD population over a long period of time, and to describe cardiac lesions.
Methods: We retrospectively reviewed the medical records of 417 patients
referred to echocardiography for KD suspicion between August 1983 and
April 2007.
Results: 210 patients met criteria for diagnosis of KD, at the age of
2.7±2.5years (median 2). Fever was present in all patients. Time to diagnosis
was 7±4.6days (median 6days), time to hospitalization 5.7±4.3days (median
5days). Time to first echocardiography was 11.4±7.8days (median 9days),
shorter in more recent period. Median time to IVIG administration was 8 days
(1 to 39). At initial evaluation, 63.8% were free from cardiac lesions, 23.8%
(52 cases) had coronary lesions (aneurisms : 25, dilatation : 27) and 12.4% had
« hyperechogen » coronary arteries. Among 52 cases with abnormal coronary
arteries, 40 were <5mm in diameter, 9 were 5-8mm, and 3 were >8mm (giant
aneurisms): one third localized on one coronary vessel, one third on 2 and one
third one all 3 coronary arteries. Echographic pericarditis was found in 31
patients, mitral insufficiency in 20 and aortic insufficiency in 2. All patients
recovered, except 1 who died from cardiogenic shock due to ruptured chordae.
Coronary lesions resolved in 17 of 52 cases (32.6%) and persisted in 35
(67.4%, i.e. 16.7% of all patients): 14 with aneurisms and 19 with dilatations.
No patient developped significant long-term coronary artery stenosis. The inci-
dence of aneurisms was lower over the past decade (7.2%).
Conclusion: In our experience, the occurrence of coronary lesions in KD
have lessened over time and long-term cardiac outcome is favourable despite
persistent coronary lesions.
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